Aurora Sheboygan Prices – Polatuzumab Vedotin-Piiq 30 Milligrams Intravenous Solution at $583.51

Polatuzumab Vedotin-Piiq is an advanced, targeted cancer therapy used primarily for certain types of lymphoma, particularly when other treatments have not been effective. At Aurora Medical Center Sheboygan County, a 30-milligram intravenous dose is priced at $583.51. This fee typically covers the medication itself and the cost of intravenous administration, but may not include additional clinical services, facility fees, or supportive care. Patients are encouraged to request a detailed, itemized estimate from the provider to fully understand all anticipated expenses and clarify what is included in the quoted price.

Cost Breakdown

• Polatuzumab Vedotin-Piiq (Medication): $583.51 per 30 mg dose
• Administration: May include nursing and IV setup fees (often billed separately)
• Facility/Infusion Suite Fees: Not always included in the listed price
• Additional Charges: Pre-treatment labs, physician consultations, and post-infusion monitoring may incur extra costs

Associated Costs

• Pre-treatment blood work and imaging
• Oncologist or specialist consultation fees
• Supportive medications (anti-nausea, steroids, etc.)
• Follow-up visits and monitoring
• Potential hospital stay if complications arise

Insurance & Payment Advice

• Contact your insurance provider to confirm coverage for Polatuzumab Vedotin-Piiq, including any pre-authorization requirements.
• Ask the billing department to provide an itemized estimate, including all associated charges for the infusion visit.
• Inquire about financial assistance or payment plans if you are uninsured or underinsured.
• Keep records of all billing codes and documentation for possible insurance appeals.

Side-Effect Considerations

• Common side effects can include low blood counts, infections, fatigue, and nerve problems.
• Discuss all potential side effects with your oncology team before starting treatment.
• Inform your care team promptly if you experience any unusual symptoms during or after infusion.

Recovery and Care Tips

• Plan for someone to accompany you to and from infusion, especially if you feel unwell afterward.
• Stay hydrated and rest as needed following treatment.
• Keep follow-up appointments for lab monitoring and assessment of treatment response.

Frequently Asked Questions

• What is Polatuzumab Vedotin-Piiq used for?
  It is used to treat certain types of lymphoma, particularly in patients who have not responded to other treatments.
• How is Polatuzumab Vedotin-Piiq administered?
  It is given as an intravenous infusion directly into the bloodstream.
• Does the price of $583.51 include all treatment costs?
  No, this price is specifically for the 30 mg dose of the medication and may not include administration, facility, or additional care fees.
• Will my insurance cover Polatuzumab Vedotin-Piiq?
  Coverage varies by plan; check with your insurer to confirm benefits and any prior authorization requirements.
• Are there financial assistance programs for this medication?
  Many hospitals and pharmaceutical companies offer assistance for eligible patients; ask your provider’s billing office about available options.
• What are the common side effects of this treatment?
  Possible side effects include low blood counts, infections, fatigue, nausea, and nerve problems.
• How many infusions will I need?
  The number of infusions depends on your specific treatment plan, which your oncologist will discuss with you.
• Can I get a detailed cost estimate for my entire treatment?
  Yes, ask the hospital for a complete, itemized estimate covering all expected costs associated with your care.
• Is it safe to drive after receiving an infusion?
  Some patients may feel fatigued or unwell; arrange for transportation until you know how you respond to treatment.
• What should I do if I experience side effects after treatment?
  Contact your care team immediately if you have concerning or severe symptoms following your infusion.
• What if my insurance denies coverage?
  Work with your provider to appeal the decision and inquire about alternative funding or charity care programs.

Aurora Medical Center Sheboygan County provides a range of medical services, including specialized treatments such as Polatuzumab Vedotin-Piiq, a medication used in cancer therapy. This intravenous solution is administered to patients as part of a treatment regimen for certain types of lymphoma. The cost for a 30-milligram dose of Polatuzumab Vedotin-Piiq at Aurora Sheboygan is $583.51, reflecting the expense of advanced cancer treatment options available at the facility. This pricing is indicative of the hospital’s commitment to offering cutting-edge therapies while maintaining transparency in healthcare costs.

What is Polatuzumab Vedotin-Piiq? – Polatuzumab Vedotin-Piiq is a targeted cancer therapy used primarily for treating certain types of lymphoma by delivering chemotherapy directly to cancer cells.

How is Polatuzumab Vedotin-Piiq administered? – It is administered intravenously, meaning it is delivered directly into the bloodstream through an IV drip.

What conditions does Polatuzumab Vedotin-Piiq treat? – This medication is used to treat specific types of lymphoma, particularly in cases where other treatments have not been effective.

Why is Polatuzumab Vedotin-Piiq so expensive? – The cost reflects the complexity of its development and production, as well as its role in providing targeted cancer treatment.

Is Polatuzumab Vedotin-Piiq covered by insurance? – Coverage can vary; patients should check with their insurance provider to determine if this treatment is included in their plan.

What are the potential side effects of Polatuzumab Vedotin-Piiq? – Common side effects may include fatigue, nausea, and low blood cell counts, but patients should discuss all potential risks with their healthcare provider.

How often is Polatuzumab Vedotin-Piiq administered? – The frequency of administration depends on the specific treatment plan prescribed by the oncologist, typically in cycles.

Can Polatuzumab Vedotin-Piiq be used in combination with other treatments? – Yes, it is often used in combination with other cancer therapies to enhance effectiveness, but this should be determined by a healthcare professional.

What should patients expect during treatment with Polatuzumab Vedotin-Piiq? – Patients can expect regular hospital visits for IV administration, along with monitoring for side effects and treatment efficacy.